Recor Medical Responds to the American Heart Association’s (AHA) Scientific Statement on Renal Denervation for the Treatment of Hypertension
August 19, 2024 09:00 ET
|
Recor Medical
Palo Alto, CA, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) greatly appreciate the American...
George Medicines files New Drug Application with FDA for novel low dose triple combination for treatment of hypertension following successful international Phase III development program
August 06, 2024 07:00 ET
|
George Medicines
George Medicines files New Drug Application with FDA for novel low dose triple combination for treatment of hypertension following successful international Phase III development program ...
First Patients Treated in Recor Medical’s Global Paradise System US Post Approval Study (US GPS) for the Treatment of Uncontrolled Hypertension with Ultrasound Renal Denervation
July 25, 2024 10:00 ET
|
Recor Medical
Palo Alto, CA, July 25, 2024 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) today announced the first patients...
Ambulatory Blood Pressure Monitoring Devices Market Predicted to Hit USD 2.58 billion, at a CAGR of 8.2% from 2024 to 2032- Report by Polaris Market Research (PMR)
May 08, 2024 08:40 ET
|
Polaris Market Research & Consulting LLP
New York, May 08, 2024 (GLOBE NEWSWIRE) -- Market Explanation: The Global Ambulatory Blood Pressure Monitoring Devices Market was valued at USD 1.27 billion in 2023 and is anticipated to generate...
George Medicines Appoints Mark Mallon as Chief Executive Officer and Board Director
April 29, 2024 07:00 ET
|
George Medicines
George Medicines Appoints Mark Mallon as Chief Executive Officer and Board Director London, UK 29 April 2024 – George Medicines, a late-stage, biopharmaceutical company addressing significant unmet...
Recor Medical Announces First Cases of Paradise Ultrasound Renal Denervation Therapy in the United Arab Emirates
April 18, 2024 11:00 ET
|
Recor Medical
Palo Alto, CA, April 18, 2024 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”), announce the first commercial...
Season Health Announces Partnership with Steward Health Care Network, Providing Food-as-Medicine Programs to Address Hypertension and Nutrition Insecurity
March 05, 2024 09:00 ET
|
Season Health
Austin, TX, March 05, 2024 (GLOBE NEWSWIRE) -- Season Health, the leading food-as-medicine platform designed to address chronic condition management at scale, today announced a partnership with...
Adherence packaging market Size Worth USD 1,686.6 Million in 2032 | Emergen Research
January 30, 2024 08:00 ET
|
Emergen Research
Vancouver, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The global adherence packaging market size was USD 917.7 Million in 2022 and is expected to register a rapid revenue CAGR of 6.2% during the forecast...
Transdermal Drug Delivery Systems Market Is Projected to Gain $87,322.40 Million by 2030: Claims Allied Market Research
November 10, 2023 06:30 ET
|
Allied Market Research
Wilmington, Delaware, Nov. 10, 2023 (GLOBE NEWSWIRE) -- According to the recent report released by Allied Market Research, the global transdermal drug delivery systems market size is predicted to...
Atenolol Market revenue to cross USD 28 Billion by 2035, says Research Nester
August 22, 2023 07:56 ET
|
Research Nester
New York, Aug. 22, 2023 (GLOBE NEWSWIRE) -- The global Atenolol Market size is expected to expand at ~ 5% CAGR from 2023 to 2035. The market is anticipated to garner a revenue of USD 28 billion by...